333
Views
37
CrossRef citations to date
0
Altmetric
Articles

Membrane processes used for removal of pharmaceuticals, hormones, endocrine disruptors and their metabolites from wastewaters: a review

, &
Pages 24146-24175 | Received 31 Jul 2015, Accepted 05 Jan 2016, Published online: 22 Feb 2016

References

  • M. Magureanua, N.B. Mandache, V.I. Parvulescu, Degradation of pharmaceutical compounds in water by non-thermal plasma treatment, Water Res. 81 (2015) 124–136.
  • P. Verlicchi, M.A. Aukidy, E. Zambello, Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review, Sci. Total. Environ. 429 (2012) 123–155.
  • J. Rivera-Utrilla, M. Sánchez-Polo, M.Á. Ferro-García, G. Prados-Joya, R. Ocampo-Pérez, Pharmaceuticals as emerging contaminants and their removal from water. A review, Chemosphere 93 (2013) 1268–1287.
  • L.J.C. Coppens, J.A.G.v. Gils, T.L.t. Laak, B.W. Raterman, A.P.v. Wezel, Towards spatially smart abatement of human pharmaceuticals in surface waters: Defining impact of sewage treatment plants on susceptible functions, Water Res. 81 (2015) 356–365.
  • D. Simazaki, R. Kubota, T. Suzuki, M. Akiba, T. Nishimura, S. Kunikane, Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health, Water Res. 76 (2015) 187–200.
  • S. Judd, B. Jefferson, Membranes for Industrial Wastewater Recovery and Re-use, Elsevier, Oxford, UK, 2003.
  • Z.F. Cui, H.S. Muralidhara, Membrane Technology: A Practical Guide to Membrane Technology and Applications in Food and Bioprocessing, Elsevier, Oxford, UK, 2010.
  • X. Wang, K. Zhang, Y. Yang, L. Wang, Z. Zhou, M. Zhu, B.S. Hsiao, B. Chu, Development of hydrophilic barrier layer on nanofibrous substrate as composite membrane via a facile route, J. Membr. Sci. 356 (2010) 110–116.
  • F.J. Benitez, J.L. Acero, F.J. Real, G. Roldán, E. Rodriguez, Ultrafiltration and nanofiltration membranes applied to the removal of the pharmaceuticals amoxicillin, naproxen, metoprolol and phenacetin from water, J. Chem. Technol. Biot. 86 (2011) 858–866.
  • J. Sipma, B. Osuna, N. Collado, H. Monclús, G. Ferrero, J. Comas, I. Rodriguez-Roda, Comparison of removal of pharmaceuticals in MBR and activated sludge systems, Desalination 250 (2010) 653–659.
  • J.L. Tambosi, R.F.d. Sena, M. Favier, W. Gebhardt, H.J. José, H.F. Schröder, R.d.F.P.M. Moreira, Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes, Desalination 261 (2010) 148–156.
  • Y. Kaya, G. Ersan, I. Vergili, Z.B. Gönder, G. Yilmaz, N. Dizge, C. Aydiner, The treatment of pharmaceutical wastewater using in a submerged membrane bioreactor under different sludge retention times, J. Membr. Sci. 442 (2013) 72–82.
  • S. Shirazian, S.N. Ashrafizadeh, Mass transfer simulation of caffeine extraction by subcritical CO2 in a hollow-fiber membrane contactor, Solvent Extr. Ion Exch. 28 (2010) 267–286.
  • J.L. Cartinella, T.Y. Cath, M.T. Flynn, G.C. Miller, K.W. Hunter Jr., A.E. Childress, Removal of natural steroid hormones from wastewater using membrane contactor processes, Environ. Sci. Technol. 40 (2006) 7381–7386.
  • N.S. Williams, H.G. Gomaa, M.B. Ray, Effect of solvent immobilization on membrane separation of ibuprofen metabolite: A green and organic solvent analysis, Sep. Purif. Technol. 115 (2013) 57–65.
  • M. Mulder, Basic Principles of Membrane Technology, Kluwer Academic Publishers, Dordrecht, Netherlands, 1996.
  • J. Wagner, Membrane Filtration Handbook Practical Tips and Hints, second ed., Osmonics, Minnetonka, US, 2001.
  • E. Saljoughi, M. Sadrzadeh, T. Mohammadi, Effect of preparation variables on morphology and pure water permeation flux through asymmetric cellulose acetate membranes, J. Membr. Sci. 326 (2009) 627–634.
  • M. Sadrzadeh, E. Saljoughi, K. Shahidi, T. Mohammadi, Preparation and characterization of a composite PDMS membrane on CA support, Polym. Adv. Technol. 21 (2009) 568–577.
  • F. Mahmoudi, E. Saljoughi, S.M. Mousavi, Promotion of polysulfone membrane by thermal-mechanical stretching process, J. Polym. Res. 20 (2013) 1–10.
  • S.M.A. Razavi, S.M. Mousavi, S.A. Mortazavi, Dynamic prediction of milk ultra’ltration performance: A neural network approach, Chem. Eng. Sci. 58 (2003) 4185–4195.
  • M. Amirilargani, E. Saljoughi, T. Mohammadi, Improvement of permeation performance of polyethersulfone (PES) ultrafiltration membranes via addition of Tween-20, J. Appl. Polym. Sci. 115 (2010) 504–513.
  • E. Shekarian, E. Saljoughi, A. Naderi, Polyacrylonitrile (PAN)/IGEPAL blend asymmetric membranes: Preparation, morphology, and performance, J. Polym. Res. 20 (2013) 1–9.
  • E. Saljoughi, S.M. Mousavi, Preparation and characterization of novel polysulfone nanofiltration membranes for removal of cadmium from contaminated water, Sep. Purif. Technol. 90 (2012) 22–30.
  • E. Saljoughi, M. Amirilargani, T. Mohammadi, Asymmetric cellulose acetate dialysis membranes: Synthesis, characterization, and performance, J. Appl. Polym. Sci. 116 (2010) 2251–2259.
  • M. Pinelo, C. Ferrer, A.S. Meyer, G. Jonsson, Controlling the rejection of protein during membrane filtration by adding selected polyelectrolytes, Sep. Purif. Technol. 85 (2012) 54–60.
  • E. Saljoughi, M. Amirilargani, T. Mohammadi, Effect of PEG additive and coagulation bath temperature on the morphology, permeability and thermal/chemical stability of asymmetric CA membranes, Desalination 262 (2010) 72–78.
  • H. You, X. Li, Y. Yang, B. Wang, Z. Li, X. Wang, M. Zhu, B.S. Hsiao, High flux low pressure thin film nanocomposite ultrafiltration membranes based on nanofibrous substrates, Sep. Purif. Technol. 108 (2013) 143–151.
  • M.A. Zazouli, H. Susanto, S. Nasseri, M. Ulbricht, Influences of solution chemistry and polymeric natural organic matter on the removal of aquatic pharmaceutical residuals by nanofiltration, Water Res. 43 (2009) 3270–3280.
  • V. Yangali-Quintanilla, S.K. Maeng, T. Fujioka, M. Kennedy, G. Amy, Proposing nanofiltration as acceptable barrier for organic contaminants in water reuse, J. Membr. Sci. 362 (2010) 334–345.
  • Y. Yoon, P. Westerhoff, S.A. Snyder, E.C. Wert, J. Yoon, Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes, Desalination 202 (2007) 16–23.
  • S.A. Snyder, S. Adham, A.M. Redding, F.S. Cannon, J. DeCarolis, J. Oppenheimer, E.C. Wert, Y. Yoon, Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals, Desalination 202 (2007) 156–181.
  • A.R.D. Verliefde, S.G.J. Heijman, E.R. Cornelissen, G. Amy, B.V.d. Bruggen, J.C.v. Dijk, Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water, Water Res. 41 (2007) 3227– 3240
  • J.L. Acero, F.J. Benitez, A.I. Leal, F.J. Real, F. Teva, Membrane filtration technologies applied to municipal secondary effluents for potential reuse, J. Hazard. Mater. 177 (2010) 390–398.
  • I. Vergili, Application of nanofiltration for the removal of carbamazepine, diclofenac and ibuprofen from drinking water sources, J. Environ. Manage. 127 (2013) 177–187.
  • K. Kimura, T. Iwase, S. Kita, Y. Watanabe, Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes, Water Res. 43 (2009) 3751–3758.
  • D. Rana, B. Scheier, R.M. Narbaitz, T. Matsuura, S. Tabe, S.Y. Jasim, K.C. Khulbe, Comparison of cellulose acetate (CA) membrane and novel CA membranes containing surface modifying macromolecules to remove pharmaceutical and personal care product micropollutants from drinking water, J. Membr. Sci. 409–410 (2012) 346–354.
  • R.M. Narbaitz, D. Rana, H.T. Dang, J. Morrissette, T. Matsuura, S.Y. Jasim, S. Tabe, P. Yang, Pharmaceutical and personal care products removal from drinking water by modified cellulose acetate membrane: Field testing, Chem. Eng. J. 225 (2013) 848–856.
  • D. Dolar, A. Vuković, D. Ašperger, K. Košutić, Effect of water matrices on removal of veterinary pharmaceuticals by nanofiltration and reverse osmosis membranes, J. Environ. Sci. 23 (2011) 1299–1307.
  • M. Omidvar, S.M. Mousavi, M. Soltanieh, A.A. Safekordi, Preparation and characterization of poly (ethersulfone) nanofiltration membranes for amoxicillin removal from contaminated water, J. Environ. Health Sci. Eng. 12 (2014) 1–9.
  • S.P. Sun, T.A. Hatton, S.Y. Chan, T.-S. Chung, Novel thin-film composite nanofiltration hollow fiber membranes with double repulsion for effective removal of emerging organic matters from water, J. Membr. Sci. 401–402 (2012) 152–162.
  • K. Košutić, D. Dolar, D. Ašperger, B. Kunst, Removal of antibiotics from a model wastewater by RO/NF membranes, Sep. Purif. Technol. 53 (2007) 244–249.
  • S. Gur-Reznik, I. Koren-Menashe, L. Heller-Grossman, O. Rufel, C.G. Dosoretz, Influence of seasonal and operating conditions on the rejection of pharmaceutical active compounds by RO and NF membranes, Desalination 277 (2011) 250–256.
  • P. Bérubé, Membrane Bioreactors: Theory and Applications to Wastewater Reuse, in Sustainability Science and Engineering, Elsevier, Amsterdam, Netherlands, 2010
  • S. Judd, The status of membrane bioreactor technology, Trends Biotechnol. 26 (2008) 109–116.
  • F.P. Shariati, M.R. Mehrnia, B.M. Salmasi, M. Heran, C. Wisniewski, M.H. Sarrafzadeh, Membrane bioreactor for treatment of pharmaceutical wastewater containing acetaminophen, Desalination 250 (2008) 798–800.
  • N.S.A. Mutamim, Z.Z. Noor, M.A.A. Hassan, A. Yuniarto, G. Olsson, Membrane bioreactor: Applications and limitations in treating high strength industrial wastewater, Chem. Eng. J. 225 (2013) 109–119.
  • N.S.A. Mutamim, Z.Z. Noor, M.A.A. Hassan, G. Olsson, Application of membrane bioreactor technology in treating high strength industrial wastewater: A performance review, Desalination 305 (2012) 1–11.
  • S.K. Maeng, B.G. Choi, K.T. Lee, K.G. Song, Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors, Water Res. 47 (2013) 3155–3162.
  • B.D. Gusseme, L. Vanhaecke, W. Verstraete, N. Boon, Degradation of acetaminophen byDelftia tsuruhatensis and Pseudomonas aeruginosa in a membrane bioreactor, Water Res. 45 (2011) 1829–1837.
  • J. Radjenovic, M. Petrovic, D. Barceló, Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor, Anal. Bioanal. Chem. 387 (2007) 1365–1377.
  • J. Radjenovic, M. Petrovic, D. Barcelo, Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment, Water Res. 43 (2009) 831–841.
  • I. Forrez, M. Carballa, G. Fink, A. Wick, T. Hennebel, L. Vanhaecke, T. Ternes, N. Boon, W. Verstraete, Biogenic metals for the oxidative and reductive removal of pharmaceuticals, biocides and iodinated contrast media in a polishing membrane bioreactor, Water Res. 45 (2011) 1763–1773.
  • R. Reif, S. Suárez, F. Omil, J.M. Lema, Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage, Desalination 221 (2008) 511–517.
  • T. Urase, C. Kagawa, T. Kikuta, Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors, Desalination 178 (2005) 107–113.
  • K.C. Wijekoon, F.I. Hai, J. Kang, W.E. Price, W. Guo, H.H. Ngo, L.D. Nghiem, The fate of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment, Bioresour. Technol. 144 (2013) 247–254.
  • M. Clara, N. Kreuzinger, B. Strenn, O. Gans, H. Kroiss, The solids retention time—A suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants, Water Res. 39 (2005) 97–106.
  • M. Bernhard, J. Muller, T.P. Knepper, Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment, Water Res. 40 (2006) 3419–3428.
  • A. Joss, E. Keller, A.C. Alder, A.G. ¨Bel, C.S. McArdell, T. Ternes, H. Siegrist, Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res. 39 (2005) 3139–3152
  • D. Serrano, S. Suarez, J.M. Lema, F. Omil, Removal of persistent pharmaceutical micropollutants from sewage by addition of PAC in a sequential membrane bioreactor, Water Res. 45 (2011) 5323–5333.
  • K. Kimura, H. Hara, Y. Watanabe, Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs), Desalination 178 (2005) 135–140.
  • M. Clara, B. Strenn, O. Gans, E. Martinez, N. Kreuzinger, H. Kroiss, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res. 39 (2005) 4797–4807.
  • C. Abegglen, A. Joss, C.S. McArdell, G. Fink, M.P. Schlu¨sener, T.A. Ternes, H. Siegrist, The fate of selected micropollutants in a single-house MBR, Water Res. 43 (2009) 2036–2046
  • B.D. Gusseme, B. Pycke, T. Hennebel, A. Marcoen, S.E. Vlaeminck, H. Noppe, N. Boon, W. Verstraete, Biological removal of 17a-ethinylestradiol by a nitrifier enrichment culture in a membrane bioreactor, Water Res. 43 (2009) 2493–2503.
  • R. López-Fernández, L. Martínez, S. Villaverde, Membrane bioreactor for the treatment of pharmaceutical wastewater containing corticosteroids, Desalination 300 (2012) 2493–2503.
  • P. Grelier, S. Rosenberger, A. Tazi-Pain, Influence of sludge retention time on membrane bioreactor hydraulic performance, Desalination 192 (2006) 10–17.
  • A. Gugliuzza, A.B. Asile, Membrane Contactors: Fundamentals, Membrane Materials and Key Operations, Woodhead, Cambridge, UK, 2013
  • J.G. Crespo, I.M. Coelhoso, R.M.C. Viegas, Membrane Contactors: Membrane Separations, Academic Press, Curia, Portugal, 2000.
  • E. Drioli, A. Criscuoli, E. Curcio, Membrane Contactors: Fundumentals, Applications and Potentialities, in Membrane Science and Technology Series, Elsevier, Amsterdam, Netherlands, 2006.
  • N.S. Williams, M.B. Ray, H.G. Gomaa, Removal of ibuprofen and 4-isobutylacetophenone by non-dispersive solvent extraction using a hollow fibre membrane contactor, Sep. Purif. Technol. 88 (2012) 61–69.
  • P.S. Nasirabadi, Treatment of pharmaceutical wastewater by membrane contactor, in Department of Chemical Engineering, Ferdowsi University of Mashhad, 2013
  • P. Dz˙ygiel, P.P. Wieczorek, Supported Liquid Membranes and Their Modifications: Definition, Classification, Theory, Stability, Application and Perspectives, Elsevier, Amsterdam, Netherlands, 2010
  • S. Phuntsho, S. Hong, M. Elimelech, H.K. Shon, Osmotic equilibrium in the forward osmosis process: Modelling, experiments and implications for process performance, J. Membr. Sci. 453 (2014) 240–252.
  • X. Jin, J. Shan, C. Wang, J. Wei, C.Y. Tang, Rejection of pharmaceuticals by forward osmosis membranes, J. Hazard. Mater. 227–228 (2012) 55–61.
  • J.A. Prince, D. Rana, G. Singh, T. Matsuura, T.J. Kai, T.S. Shanmugasundaram, Effect of hydrophobic surface modifying macromolecules on differently produced PVDF membranes for direct contact membrane distillation, Chem. Eng. J. 242 (2014) 387–396.
  • G.C.C. Yang, C.-H. Yen, The use of different materials to form the intermediate layers of tubular carbon nanofibers/carbon/alumina composite membranes for removing pharmaceuticals from aqueous solutions, J. Membr. Sci. 425–426 (2013) 121–130.
  • C.C. Jara, D. Fino, V. Specchia, G. Saracco, P. Spinelli, Electrochemical removal of antibiotics from wastewaters, Appl. Catal. 70 (2007) 479–487.
  • S. Miralles-Cuevas, A. Arqués, M.I. Maldonado, J.A. Sánchez-Pérez, S.M. Rodríguez, Combined nanofiltration and photo-Fenton treatment of water containing micropollutants, Chem. Eng. J. 224 (2013) 89–95.
  • G. Laera, M.N. Chong, B. Jin, A. Lopez, An integrated MBR–TiO2 photocatalysis process for the removal of Carbamazepine from simulated pharmaceutical industrial effluent, Bioresour. Technol. 102 (2011) 7012–7015.
  • S. Mozia, A.W. Morawski, The performance of a hybrid photocatalysis–MD system for the treatment of tap water contaminated with ibuprofen, Catal. Today. 193 (2012) 213–220.
  • X. Yang, R.C. Flowers, H.S. Weinberg, P.C. Singer, Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant, Water Res. 45 (2011) 5218–5228.
  • W. Xue, C. Wu, K. Xiao, X. Huang, H. Zhou, H. Tsuno, H. Tanaka, Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation, Water Res. 44 (2010) 5999–6010.
  • F. Saravia, F.H. Frimmel, Role of NOM in the performance of adsorption-membrane hybrid systems applied for the removal of pharmaceuticals, Desalination 224 (2008) 168–171.
  • E. Sahar, I. David, Y. Gelman, H. Chikurel, A. Aharoni, R. Messalem, A. Brenner, The use of RO to remove emerging micropollutants following CAS/UF or MBR treatment of municipal wastewater, Desalination 273 (2011) 142–147.
  • I. Senta, M. Matŏsić, H.K. Jakopović, S. Terzic, J. Ćurko, I. Mijatović, Removal of antimicrobials using advanced wastewater treatment, J. Hazard. Mater. 192 (2011) 319–328.
  • A. Pollice, G. Laera, D. Cassano, S. Diomede, A. Pinto, A. Lopez, G. Mascolo, Removal of nalidixic acid and its degradation products by an integrated MBR-ozonation system, J. Hazard. Mater. 203–204 (2012) 46–52.
  • D. Dolar, M. Gros, S. Rodriguez-Mozaz, J. Moreno, J. Comas, I. Rodriguez-Roda, D. Barceló, Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR–RO, J. Hazard. Mater. 239–240 (2012) 64–69.
  • A.L. Alpatova, S.H. Davies, S.J. Masten, Hybrid ozonation-ceramic membrane filtration of surface waters: The effect of water characteristics on permeate flux and the removal of DBP precursors, dicloxacillin and ceftazidime, Sep. Purif. Technol. 107 (2013) 179–186.
  • S.D. Kim, J. Cho, I.S. Kim, B.J. Vanderford, S.A. Snyder, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters, Water Res. 41 (2007) 1013–1021.
  • J. Radjenovic, M. Petrovic, F. Ventura, D. Barcelo, Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment, Water Res. 42 (2008) 3601–3610.
  • V.C. Sarasidis, K.V. Plakas, S.I. Patsios, A.J. Karabelas, Investigation of diclofenac degradation in a continuous photo-catalytic membrane reactor. Influence of operating parameters, Chem. Eng. J. 239 (2014) 299–311.
  • M. Bodzek, M. Dudziak, Removal of natural estrogens and synthetic compounds considered to be endocrine disrupting substances (EDs) by coagulation and nanofiltration, Pol. J. Environ. Stud. 15 (2006) 35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.